Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report

Show full item record



Permalink

http://hdl.handle.net/10138/300310

Citation

Seppala , T T , Ahadova , A , Dominguez-Valentin , M , Macrae , F , Evans , D G , Therkildsen , C , Sampson , J , Scott , R , Burn , J , Möslein , G , Bernstein , I , Holinski-Feder , E , Pylvänäinen , K , Renkonen-Sinisalo , L , Lepistö , A , Lautrup , C K , Lindblom , A , Plazzer , J-P , Winship , I , Tjandra , D , Katz , L H , Aretz , S , Hueneburg , R , Holzapfel , S , Heinimann , K , Della Valle , A , Neffa , F , Gluck , N , Cappel , W H D V T N , Vasen , H , Morak , M , Steinke-Lange , V , Engel , C , Rahner , N , Schmiegel , W , Vangala , D , Thomas , H , Green , K , Lalloo , F , Crosbie , E J , Hill , J , Capella , G , Pineda , M , Navarro , M , Blanco , I , ten Broeke , S , Nielsen , M , Ljungmann , K , Nakken , S , Lindor , N , Frayling , I , Hovig , E , Sunde , L , Kloor , M , Mecklin , J-P , Kalager , M & Moller , P 2019 , ' Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report ' , Hereditary Cancer in Clinical Practice , vol. 17 , 8 . https://doi.org/10.1186/s13053-019-0106-8

Title: Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report
Author: Seppala, Toni T.; Ahadova, Aysel; Dominguez-Valentin, Mev; Macrae, Finlay; Evans, D. Gareth; Therkildsen, Christina; Sampson, Julian; Scott, Rodney; Burn, John; Möslein, Gabriela; Bernstein, Inge; Holinski-Feder, Elke; Pylvänäinen, Kirsi; Renkonen-Sinisalo, Laura; Lepistö, Anna; Lautrup, Charlotte Kvist; Lindblom, Annika; Plazzer, John-Paul; Winship, Ingrid; Tjandra, Douglas; Katz, Lior H.; Aretz, Stefan; Hueneburg, Robert; Holzapfel, Stefanie; Heinimann, Karl; Della Valle, Adriana; Neffa, Florencia; Gluck, Nathan; Cappel, Wouter H. de Vos Tot Nederveen; Vasen, Hans; Morak, Monika; Steinke-Lange, Verena; Engel, Christoph; Rahner, Nils; Schmiegel, Wolff; Vangala, Deepak; Thomas, Huw; Green, Kate; Lalloo, Fiona; Crosbie, Emma J.; Hill, James; Capella, Gabriel; Pineda, Marta; Navarro, Matilde; Blanco, Ignacio; ten Broeke, Sanne; Nielsen, Maartje; Ljungmann, Ken; Nakken, Sigve; Lindor, Noralane; Frayling, Ian; Hovig, Eivind; Sunde, Lone; Kloor, Matthias; Mecklin, Jukka-Pekka; Kalager, Mette; Moller, Pal
Other contributor: University of Helsinki, Clinicum
University of Helsinki, Department of Surgery
University of Helsinki, II kirurgian klinikka




Date: 2019-02-28
Language: eng
Number of pages: 8
Belongs to series: Hereditary Cancer in Clinical Practice
ISSN: 1731-2302
DOI: https://doi.org/10.1186/s13053-019-0106-8
URI: http://hdl.handle.net/10138/300310
Abstract: BackgroundRecent epidemiological evidence shows that colorectal cancer (CRC) continues to occur in carriers of pathogenic mismatch repair (path_MMR) variants despite frequent colonoscopy surveillance in expert centres. This observation conflicts with the paradigm that removal of all visible polyps should prevent the vast majority of CRC in path_MMR carriers, provided the screening interval is sufficiently short and colonoscopic practice is optimal.MethodsTo inform the debate, we examined, in the Prospective Lynch Syndrome Database (PLSD), whether the time since last colonoscopy was associated with the pathological stage at which CRC was diagnosed during prospective surveillance. Path_MMR carriers were recruited for prospective surveillance by colonoscopy. Only variants scored by the InSiGHT Variant Interpretation Committee as class 4 and 5 (clinically actionable) were included. CRCs detected at the first planned colonoscopy, or within one year of this, were excluded as prevalent cancers.ResultsStage at diagnosis and interval between last prospective surveillance colonoscopy and diagnosis were available for 209 patients with 218 CRCs, including 162 path_MLH1, 45 path_MSH2, 10 path_MSH6 and 1 path_PMS2 carriers. The numbers of cancers detected within 3.5years since last colonoscopy were 36, 93, 56 and 33, respectively. Among these, 16.7, 19.4, 9.9 and 15.1% were stage III-IV, respectively (p=0.34). The cancers detected more than 2.5years after the last colonoscopy were not more advanced than those diagnosed earlier (p=0.14).ConclusionsThe CRC stage and interval since last colonoscopy were not correlated, which is in conflict with the accelerated adenoma-carcinoma paradigm. We have previously reported that more frequent colonoscopy is not associated with lower incidence of CRC in path_MMR carriers as was expected. In contrast, point estimates showed a higher incidence with shorter intervals between examinations, a situation that may parallel to over-diagnosis in breast cancer screening. Our findings raise the possibility that some CRCs in path_MMR carriers may spontaneously disappear: the host immune response may not only remove CRC precursor lesions in path_MMR carriers, but may remove infiltrating cancers as well. If confirmed, our suggested interpretation will have a bearing on surveillance policy for path_MMR carriers.
Subject: Mismatch repair
Microsatellite instability
Lynch syndrome
Hereditary cancer
Colorectal cancer
Hereditary nonpolyposis colorectal cancer
Colonoscopy
Endoscopy
Surveillance
Screening
Over-diagnosis
COLORECTAL-CANCER
COLONOSCOPIC SURVEILLANCE
RISK
FAMILIES
MUTATION
ADENOMA
3122 Cancers
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
s13053_019_0106_8.pdf 716.8Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record